Literature DB >> 22608001

Idiopathic avascular necrosis of the scaphoid: 10 new cases and a review of the literature. Indications for Preiser's disease.

H Lenoir1, B Coulet, C Lazerges, O Mares, P Croutzet, M Chammas.   

Abstract

INTRODUCTION: Avascular necrosis of the scaphoid (Preiser's disease) is a rare entity for which there are no treatment guidelines to date. The aim of this study was to delineate the optimal treatment at different stages of this disease, based on an analysis of the cases treated in our department.
MATERIALS AND METHODS: Ten wrists (nine patients) were retrospectively reviewed after a mean 92 months of follow-up. The initial diagnosis was stage II avascular necrosis in four cases, stage III in four cases and stage IV in two cases. These patients were treated by conservative treatment (non surgical) in three cases, vascularized bone graft in two and palliative treatments (proximal row carpectomy or partial fusion) in five. Radiological examination, sometimes completed by MRI, and functional assessment of range of motion, grip strength and Mayo Wrist Score were performed.
RESULTS: Completely different results were obtained in the two stage II cases treated by conservative treatment, while functional results improved in the two cases treated by vascularized bone graft with regression of necrosis on MRI. Pain improved following palliative treatment in 4/5 stage III and IV wrists. Functional results were satisfactory with conservative treatment in one stage IV case for 13 years but worsened at the final follow-up assessment. DISCUSSION: A review of the literature, including 126 cases in 29 articles clarified the role of conservative treatment, vascularized bone grafts and proximal row carpectomy in the treatment of avascular necrosis of the scaphoid. Conservative treatment is ineffective in the early stages and nearly always results in disease progression. In contrast vascularized bone grafts can stop or even reverse damage at stage II. Palliative treatment is indicated when facing irreversible lesions. LEVEL OF EVIDENCE: Level IV - Retrospective study.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22608001     DOI: 10.1016/j.otsr.2011.11.013

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  7 in total

1.  Bilateral Preiser Disease in a Patient with Sickle Cell Anemia.

Authors:  Joseph Catapano; Oluwatola O Overduin; Herbert P von Schroeder
Journal:  J Hand Microsurg       Date:  2020-08-10

2.  Avascular Necrosis of the Scaphoid Preiser Disease.

Authors:  Femke M A P Claessen; Ilse Schol; Gregory P Kolovich; David Ring
Journal:  Arch Bone Jt Surg       Date:  2020-01

3.  Treatment of Preiser disease with vascularized bone graft from the distal radius: a report of two cases.

Authors:  Sérgio Augusto Machado da Gama; Marcelo Rosa de Rezende; Samuel Ribak
Journal:  Hand (N Y)       Date:  2015-09

4.  Preiser disease after repeated local glucocorticoid injections: A case report.

Authors:  Yuji Tomori; Norio Motoda; Ryuji Ohashi; Takuya Sawaizumi; Mitsuhiko Nanno; Shinro Takai
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Preiser disease in a child before complete ossification of the scaphoid: a case report.

Authors:  Taketsugu Fujibuchi; Hiroshi Imai; Akihiro Jono; Hiroshi Kiyomatsu; Hiromasa Miura
Journal:  BMC Musculoskelet Disord       Date:  2022-03-18       Impact factor: 2.362

6.  A Debilitating Orthopaedic Complication following Corticosteroid Therapy for Polymyalgia Rheumatica.

Authors:  Paul Rai; Vinay Takwale
Journal:  Case Rep Rheumatol       Date:  2014-04-06

7.  Clinical outcomes of nonsurgical treatment for Preiser disease.

Authors:  Yuji Tomori; Mitsuhiko Nanno; Shinro Takai
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.